Vena Vitals
- Company typePrivate
- Founded2020
- HeadquartersIrvine, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
Vena Vitals firmographics
Firmographics- Name
- Vena Vitals
- Legal name
- Vena Vitals, Inc.
- Website
- https://venavitals.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Vena Vitals industry classification
Industry- Product category
- Medical Patient Monitoring Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Other Measuring and Controlling Device Manufacturing (334519)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845), Measuring & Controlling Devices, Nec (3829)
- akta.pro primary industry
- Blood Pressure Monitoring (Cuff & Cuffless) (HLAHACAC)
- akta.pro secondary industries
- Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous) (HLAHACAA), Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI), Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Fall Detection, Safety & Emergency Response (PERS, Smart Home Health Sensors) (HLAHACAG)
Keywords
Where Vena Vitals is headquartered
LocationHeadquarters
- HQ city
- Irvine
- HQ country
- United States
- HQ region
- North America
Markets served
Vena Vitals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Revenue model
- Medical Device Sales: Vena Vitals generates revenue through the sale of its VeriTrack continuous blood pressure monitoring system. The device is intended for hospital, clinic, and home use across multiple care settings including operating rooms and sleep facilities.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Vena Vitals product offering
Product offeringCore offering
Vena Vitals develops and manufactures the VeriTrack continuous blood pressure monitoring system, a soft, wearable capacitive pressure sensor built on patented wrinkled metal technology. The sensor is placed externally on the skin over a palpable artery (such as the dorsalis pedis artery on the foot) to capture every heartbeat with high fidelity and resolution comparable to the gold standard Arterial Line. The system targets anesthesiologists, sleep physicians, hospitals, clinics, and at-home care for noninvasive continuous blood pressure monitoring, and has been submitted for FDA 510(k) evaluation.
Product overview
Vena Vitals offers a single unified product: the VeriTrack system, a continuous blood pressure monitoring device. The system consists of a soft, stretchable capacitive pressure sensor with patented wrinkled metal technology that is placed over a palpable artery (such as the dorsalis pedis artery on the foot) to capture continuous blood pressure data. The device recently underwent FDA 510(k) submission and is not yet commercially available.
Differentiator
Problem solved
Functional benefit
Products and services
- VeriTrack Continuous Blood Pressure Monitoring System A continuous blood pressure monitoring system using a soft, flexible capacitive pressure sensor with patented wrinkled metal technology. The sensor is placed on the skin over a palpable artery, such as the dorsalis pedis artery on the foot, to capture every heartbeat with high fidelity, sensitivity, and resolution comparable to the gold standard Arterial Line. It is intended for anesthesiologists in operating rooms, sleep physicians, hypotensive and hypertensive event detection in hospitals and clinics, and at-home continuous blood pressure monitoring.
Quantifiable outcome
- Real-time, accurate blood pressure monitoring comparable to the gold standard Arterial Line
Companies that use Vena Vitals
Customer profileSegments4 records
Ideal customer profiles2 records
Vena Vitals technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Vena Vitals partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights4 records
Vena Vitals competitors and assessment
Company assessmentDirect peers
- Biobeat: Biobeat develops cuffless, continuous remote patient monitoring wearables measuring blood pressure, heart rate, and other vitals — directly competing with Vena Vitals' VeriTrack in clinical and remote settings.
- Aktiia: Aktiia offers a cuffless, continuous blood pressure monitoring wrist-worn device, targeting the same core problem (continuous, non-invasive BP) as Vena Vitals' VeriTrack system.
- Caretaker Medical: Caretaker Medical produces a continuous, non-invasive blood pressure and hemodynamic monitoring device, directly competing with VeriTrack in hospital and clinical use cases.
- Finapres: Finapres specializes in continuous non-invasive finger-cuff blood pressure monitoring technologies, competing in the same clinical-grade continuous BP category as Vena Vitals.
Broad incumbents
- Edwards Lifesciences: Edwards is the dominant player in invasive arterial line-based hemodynamic monitoring (FloTrac, ClearSight) and represents the gold-standard incumbent that VeriTrack aims to complement or displace non-invasively.
- Masimo: Masimo is a major patient monitoring incumbent with broad vital signs and continuous monitoring offerings, including the recently expanded continuous BP roadmap, overlapping with Vena Vitals' target OR and hospital settings.
- Medtronic: Medtronic's patient monitoring business (acquired from Covidien) provides continuous vitals in hospital settings and represents a potential channel competitor and partner for cuffless BP innovations.
- GE HealthCare: GE HealthCare provides continuous patient monitoring systems across hospitals and ORs, making it a broad incumbent whose installed base VeriTrack would need to integrate with or compete against.
- Philips: Philips Patient Monitoring is an established OR and ICU monitoring incumbent with a global hospital footprint, representing both a competitive threat and a potential partnership channel for VeriTrack.
Emerging players
- Apple: Apple's smartwatch blood pressure and cardiovascular features, while consumer-oriented and intermittent, place it as an emerging player shaping expectations around cuffless BP and could converge on continuous monitoring over time.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Vena Vitals social profiles
Digital presenceVena Vitals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vena Vitals leadership team
Management profileNumber of profiles
Profiles2 records
Vena Vitals funding detail
Funding detailFunding overview
Funding rounds4 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vena Vitals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vena Vitals
What does Vena Vitals do?
Vena Vitals develops and manufactures the VeriTrack continuous blood pressure monitoring system, a soft, wearable capacitive pressure sensor built on patented wrinkled metal technology. The sensor is placed externally on the skin over a palpable artery (such as the dorsalis pedis artery on the foot) to capture every heartbeat with high fidelity and resolution comparable to the gold standard Arterial Line. The system targets anesthesiologists, sleep physicians, hospitals, clinics, and at-home care for noninvasive continuous blood pressure monitoring, and has been submitted for FDA 510(k) evaluation.
Is Vena Vitals a public or private company?
Vena Vitals is a private company. It is classified as venture growth investor backed and is currently operating.
When was Vena Vitals founded?
Vena Vitals was founded in 2020. It employs 1 to 10 people.
Where is Vena Vitals based?
Vena Vitals is headquartered in Irvine, United States, in the North America region.
How does Vena Vitals make money?
One revenue line is on record: medical Device Sales.
Who are Vena Vitals's main competitors?
Direct peers on record are Biobeat, Aktiia, Caretaker Medical and Finapres. Broad incumbents are Edwards Lifesciences, Masimo, Medtronic, GE HealthCare and Philips. Apple is listed as an emerging player.
Does Vena Vitals have an API?
No public API is recorded for Vena Vitals.
What industry is Vena Vitals in?
Vena Vitals's product category is Medical Patient Monitoring Devices. Its primary akta.pro industry code is HLAHACAC, Blood Pressure Monitoring (Cuff & Cuffless), with a secondary code of HLAHACAA, Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous). Its NAICS code is 334510 and its SIC code is 3841.